FibroBiologics, Inc.

As of June 2, 2025, the trend is mildly bearish due to daily moving averages indicating a bearish trend, while weekly MACD and KST show mildly bullish signals, resulting in mixed indicators and a lack of strong momentum.

FibroBiologics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $5 million and a market cap of $28.82 million. The company has no dividend yield and significant negative financial metrics.

As of Jun 18, FibroBiologics, Inc. has a market capitalization of 28.82 million and reported net sales of 0.00 million with a net profit of -7.67 million over the last four quarters. The balance sheet shows shareholder's funds of 2.73 million and total assets of 22.12 million.